Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
164.8 USD | +0.07% | +1.64% | +6.43% |
02:44pm | Deutsche Bank Raises AbbVie's Price Target to $175 Form $170 | MT |
02:27pm | Alvotech Signs Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in US | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.43% | 292B | |
+26.83% | 672B | |
+23.89% | 550B | |
-7.09% | 351B | |
+14.99% | 317B | |
+2.57% | 211B | |
-0.28% | 203B | |
-11.41% | 144B | |
-8.43% | 141B | |
-4.20% | 113B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie : Wins FDA Approval for Dalvance in Treating Acute Bacterial Skin, Skin Structure Infections